Skip to Content

RDY 612 (Pramipexole Dihydrochloride Extended-Release 0.75 mg)

Pill with imprint RDY 612 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.75 mg. It is supplied by Dr. Reddy's Laboratories Limited.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 612

Pramipexole dihydrochloride extended-release 0.75 mg RDY 612 Front
Pramipexole dihydrochloride extended-release 0.75 mg RDY 612 Back

Pramipexole Dihydrochloride Extended-Release

Imprint
RDY 612
Strength
0.75 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Limited
National Drug Code (NDC)
55111-0612

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.